- Clinical studies involving remdesivir as a treatment for the coronavirus has yielded encouraging results.
- Remdesivir was developed by Gilead as a drug to treat Ebola patients, but the FDA approved it as a coronavirus treatment late last week.
- Gilead CEO Daniel O’Day said that remdesivir will be used on coronavirus patients starting next week. O’Day also said that Gilead will be giving away its entire supply of Remdesivir.
- Visit BGR’s homepage for more stories.
A few weeks ago, a research study in the New England Journal of Medicine revealed that a good percentage of coronavirus patients exhibited signs of improvement when treated with Remdesivir, a drug that was previously developed by Gilead to help treat Ebola patients.
Now comes word from Gilead CEO Daniel O’Day that remdesivir will be rolled out on a larger scale to coronavirus patients in areas that have been hit particularly hard by the virus.
Today’s Top Deals
- Today’s best deals: 80¢ face masks, KN95 masks in stock, hand sanitizer, AirPods 2 blowout, $8 wireless charger, more
- KN95 face masks are actually in stock right now at Amazon
- Hurry: Hand sanitizer is still in stock right now at Amazon
Trending Right Now:
- Here’s when the next round of coronavirus stimulus checks will arrive
- The scariest coronavirus symptom might be more serious than we thought
- Best Buy’s huge limited-time Apple sale is packed with deals – here are the 10 best ones
Promising coronavirus drug remdesivir arrives in hospitals this week originally appeared on BGR.com on Mon, 4 May 2020 at 16:03:20 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report